ArticleRecent patents on biotechnology2026
Evaluation of Pharmacognostical and Anti-Ulcer Potential of
Article in Recent patents on biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVernonia anthelmintica (L.) Willd., commonly known as Kalijiri, has been used for the treatment of different ailments, including stomach aches, skin diseases, asthma, and cough, and is popular as a powerful anthelmintic agent.
aimsThis study aimed to evaluate the pharmacognostical, physicochemical, and phytochemical parameters along with the in-vivo antiulcer activity of the seeds of Vernonia anthelmintica (L.) Willd.
methodsThe pharmacognostical evaluation included macroscopic and microscopic characterization of the seed and powder of
resultsThe morphological characteristics of DISCUSSION: This study confirmed the identity, quality, and bioactive content of V. anthelmintica seeds, highlighting strong antioxidant and significant antiulcer activity of the ethanolic extract. The results support traditional use and suggest potential for developing patented herbal formulations, encouraging further research on its therapeutic applications.
conclusionThis research plays a crucial role in raising awareness about the gastroprotective potential of V. anthelmintica. It encourages researchers to explore and further investigate its gastroprotective properties across varying doses and alternative screening models other than those used in this study.
Indexed as
Identifiers
40611428What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.